Reversibility of hepatic fibrosis in autoimmune hepatitis

Annals of Internal Medicine

Volumn 127, Issue 11, 1997, Pages 981-985

  Dufour, Jean François ^a   DeLellis, Ronald ^a,b   Kaplan, Marshall M ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER REGENERATION; MALE; PRIORITY JOURNAL;

EID: 0030692704     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-11-199712010-00006     Document Type: Article

References (14)

1. Crawford JM. The liver and the biliary tract. In: Cotran RS, Robbins SL, Kumar V, Schoen FJ, eds. Pathologic Basis of Disease. 5th ed. Philadelphia: WB Saunders; 1994; 831-96.
2. Hall PD. Alcoholic liver disease. In: MacSween RN, Anthony PP, Scheuer PJ, eds. Pathology of the Liver. 2d ed. New York: Churchill Livingstone; 1987: 291.
3. Powell LW, Kerr JF. Reversal of "cirrhosis" in idiopathic hemochromatosis following long-term intensive venesection therapy. Australas Ann Med. 1970; 2:54-7.
4. Falkmer S, Samuelson G, Sjölin S. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease. Pediatrics. 1970;45:260-8.
5. Kaplan MM, DeLellis RA, Wolfe HJ. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment. Ann Intern Med. 1997;126:682-8.
6. Tassoni JP Jr, Kaplan MM. Rapidly progressive liver failure in a 65-year-old woman. Gastroenterology. 1991;100:1492-8.
7. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998-1005.
8. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1:431-5.
9. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993:328:1828-36.
10. Greenwel P, Geerts A, Ogata I, Solis-Herruzo JA, Rojkind M. Liver fibrosis. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Schafritz DA, eds. The Liver: Biology and Pathobiology. 3d ed. New York: Raven Pr; 1994.
11. Zimmermann H, Reichen J, Zimmermann A, Sagesser H, Thenisch B, Hoflin F. Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat. Gastroenterology. 1992;103:579-89.
12. Dunn MA, Cheever AW, Paglia LM, Kelly EP, Duvall RH, Andrade ZA, et al. Reversal of advanced liver fibrosis in rabbits with Schistosomiasis Japonica. Am J Trop Med Hyg. 1994;50:499-505.
13. Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med. 1979;39:667-9.
14. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1994;20(1 Pt 1): 15-20.